Pfizer Q4 Earnings: Solid Results, But Guidance And Patent Concerns Drive Stock Down (PFE)
1. Pfizer is experiencing competitive pressures in the vaccine market. 2. Market reactions suggest uncertainty around PFE’s future revenue growth. 3. Analysts are closely monitoring PFE amidst shifting investor sentiment.